CiToxLAB appoints Alan Bartlett as Senior Director, Global Laboratory Operations
CiToxLAB, a leading CRO in the field of non-clinical research, announces that Alan Bartlett has...
Denali Therapeutics Announces First Clinical Trial Application, Key Collaborations And $130M Series B
Denali Therapeutics Inc announced several critical milestones in the company's growth, including its first Clinical...
CSM To Host A Live Webinar On Direct-To-Patient Shipping For Clinical Trials
CSM, a leading provider of clinical trial supply services, will conduct an upcoming webinar, "Discover...
AstraZeneca and Lilly receive FDA Fast Track designation for AZD3293, an investigational treatment for...
AstraZeneca and Eli Lilly and Company (Lilly) announced they have received US FDA Fast Track...
KalVista begins phase 1 study of KVD818 in hereditary angioedema
KalVista Pharmaceuticals announced the dosing of the first subject in a first-in-human clinical trial to...
Alzheimer’s drug shows promise for patients in phase III trial
At the Alzheimer's Association International Conference 2016 (AAIC 2016), held in Toronto, Canada, researchers reveal...
AstraZeneca Provides Update on Phase III Trial of Selumetinib in Non-Small Cell Lung Cancer
AstraZeneca announced results from the Phase III SELECT-1 trial of the MEK 1/2 inhibitor, selumetinib,...
Antibe Therapeutics Announces Successful Phase 2 Trial Of ATB-346 In Osteoarthritis
Antibe Therapeutics Inc. is pleased to announce the successful completion of its phase 2 clinical...
ClinicalRM And Mapp Biopharmaceutical Combine Efforts To Continue The Fight Against Ebola
ClinicalRM will again deploy its boots-on-the-ground approach to fighting Ebola Virus Disease (EVD) with an...
Inovio Pharmaceuticals Doses First Subject in Zika Vaccine Clinical Trial
Inovio Pharmaceuticals, Inc announced the dosing of the first subject in its multi-center phase I...
